Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 13, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 104
- +9 vs. Q1 2026
- Portfolio value
- $2.04B
- +$339.7M (+19.9%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| XENEXenon Pharmaceuticals Inc. | COM | 1,595,000 | $96.3M | 4.7% | −80,000−4.8% | Reduced | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,279,134 | $113.6M | 5.6% | 00.0% | Unchanged | History |
| APGEApogee Therapeutics, Inc. | COM | 987,000 | $131.0M | 6.4% | −297,926−23.2% | Reduced | History |
| ROIVRoivant Sciences Ltd. | SHS | 3,750,000 | $132.7M | 6.5% | +950,000+33.9% | Added | History |
Options (8)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| MRNAModerna, Inc. | Stock | $35.0M | $33.3M |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | – | $31.5M |
| LLYEli Lilly & Co | Stock | – | $24.0M |
| OMEROmeros Corp | COM | $13.4M | – |
| ALKSAlkermes plc. | SHS | – | $13.1M |
| QUREuniQure N.V. | SHS | – | $9.21M |
| EVMNEvommune, Inc. | COM SHS | $6.65M | – |
| SMMTSummit Therapeutics Inc. | COM | – | $1.46M |
Sold out since Q1 2026 (8)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,400,000 | $55.6M | 3.3% | History |
| ACLXArcellx, Inc. | COMMON STOCK | 362,764 | $41.7M | 2.4% | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 562,631 | $29.7M | 1.7% | History |
| BBIOBridgeBio Pharma, Inc. | COM | 150,000 | $11.1M | 0.7% | History |
| WVEWave Life Sciences, Inc. | SHS | 1,401,727 | $10.2M | 0.6% | History |
| Celcuity Inc.15102KAA8 | NOTE 2.750% 8/0 | – | $7.31M | 0.4% | – |
| CORTCorcept Therapeutics Inc | COM | 50,000 | $2.02M | 0.1% | History |
| KZRKezar Life Sciences, Inc. | COM | 229,076 | $1.70M | 0.1% | History |